732 related articles for article (PubMed ID: 18563785)
1. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
Lindholm E; Brevinge H; Haglind E
Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
3. Early detection of colorectal cancer with faecal occult blood test screening.
Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
[TBL] [Abstract][Full Text] [Related]
4. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
5. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
[TBL] [Abstract][Full Text] [Related]
6. [Randomized controlled trial of sequence mass screening program for colorectal cancer].
Liu X; Zheng S; Chen K; Ma X; Zhou L; Yu H; Yao K; Chen K; Cai S; Zhang S
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):430-3. PubMed ID: 11860828
[TBL] [Abstract][Full Text] [Related]
7. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds.
Kronborg O; Jørgensen OD; Fenger C; Rasmussen M
Scand J Gastroenterol; 2004 Sep; 39(9):846-51. PubMed ID: 15513382
[TBL] [Abstract][Full Text] [Related]
8. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
Malila N; Hakama M; Pukkala E
Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
[TBL] [Abstract][Full Text] [Related]
9. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.
Mandel JS; Bond JH; Church TR; Snover DC; Bradley GM; Schuman LM; Ederer F
N Engl J Med; 1993 May; 328(19):1365-71. PubMed ID: 8474513
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
[TBL] [Abstract][Full Text] [Related]
11. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
Musil D; Tillich J
Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
[TBL] [Abstract][Full Text] [Related]
12. Recommendations on population screening for colorectal cancer in New Zealand. Members of the National Health Committee Working Party on Population Screening for Colorectal Cancer.
N Z Med J; 1999 Jan; 112(1080):4-6. PubMed ID: 10073156
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
14. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
15. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Rabeneck L; Paszat LF
Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
[TBL] [Abstract][Full Text] [Related]
16. [Mass screening for colorectal cancer].
Faivre J; Tazi MA; Launoy G
Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S7-14. PubMed ID: 8935859
[TBL] [Abstract][Full Text] [Related]
17. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II.
Rasmussen M; Fenger C; Kronborg O
Scand J Gastroenterol; 2003 Jan; 38(1):114-8. PubMed ID: 12608473
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening.
Berry DP; Clarke P; Hardcastle JD; Vellacott KD
Br J Surg; 1997 Sep; 84(9):1274-6. PubMed ID: 9313712
[TBL] [Abstract][Full Text] [Related]
20. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
Slusser SO; Liberski SM; McGarrity TJ
Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]